Related Experiment Video
Updated: May 28, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Individualized and targeted coagulation management in bleeding trauma patients
Nikolaus Hofmann1,2, Herbert Schöchl2, Johannes Gratz1
1Department of Anaesthesia, Intensive Care Medicine and Pain Medicine, Division of General Anaesthesia and Intensive Care Medicine, Medical University of Vienna.
Individualized hemostatic management using point-of-care diagnostics is superior to fixed-ratio transfusions for bleeding trauma patients. This personalized approach optimizes resuscitation, avoiding risks associated with standardized treatments.
Area of Science:
- Trauma Care
- Hemorrhage Management
- Coagulation Disorders
Background:
- Massive traumatic hemorrhage frequently leads to coagulopathy.
- Empiric treatments often fail to reverse coagulopathy effectively.
- Current resuscitation strategies include fixed-ratio transfusion and individualized therapy.
Purpose of the Study:
- To review evidence on hemostatic management in bleeding trauma.
- To compare coagulation factor concentrates and fixed-ratio transfusion strategies.
- To discuss benefits and limitations of different resuscitation approaches.
Main Methods:
- Review of current evidence on trauma resuscitation.
- Analysis of fixed-ratio transfusion concepts.
- Evaluation of individualized hemostatic therapy using point-of-care diagnostics.
Main Results:
- Fixed-ratio transfusion mimics reconstituted whole blood but risks over/undertransfusion.
- Individualized therapy using viscoelastic tests enables targeted treatment.
- Coagulopathy from hemorrhage is often resistant to empiric reversal.
Conclusions:
- Individualized, goal-directed hemostasis offers advantages over fixed-ratio transfusion.
- Further research is needed for direct comparison of these strategies.
- Point-of-care diagnostics facilitate personalized trauma resuscitation.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...

